Head of Biotherapeutics (Sr. Director or VP Level) at Manifold Bio

Boston, Massachusetts, United States

Manifold Bio Logo
Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
BiotechnologyIndustries

Requirements

  • Experience taking multiple molecules through IND and into the clinic
  • Deep understanding of protein production techniques, including mammalian cell culture and purification/characterization approaches
  • Expertise in novel biotherapeutic modalities, across a range of formats
  • Extensive experience leading cross-functional teams
  • Experience with complex biologics (e.g. multispecifics)
  • Preferred Qualifications
  • Experience with drug development in neuroscience
  • Experience liaising with CDMOs through IND
  • Experience with generative AI models for protein design

Responsibilities

  • Leading internal protein sciences and protein engineering teams
  • Own strategy for early stage de-risking and optimization of lead molecules
  • Own strategy for developability assessment
  • Work with internal and external team members to ensure cost-effective and timely drug manufacture
  • Build internal expertise on cutting-edge protein engineering techniques
  • Guide prioritization for internal protein generation efforts, balancing between screening and lead characterization
  • Build an R&D-to-development pipeline for lead candidates
  • Utilize state of the art techniques to drive the development of best-in-class therapeutic candidates
  • Stay up to speed on cutting edge research and industry standards for protein therapeutics

Skills

Protein Engineering
Biologics Manufacturing
CMC
IND
High-Throughput Screening
Protein Production
Computational Design
Antibody Engineering

Manifold Bio

Designs precision biologics using in vivo methods

About Manifold Bio

Manifold Bio specializes in creating precision biologics for the pharmaceutical industry, focusing on drug design and development. Their main product is an in vivo drug design platform, which allows for testing drugs within living organisms rather than in laboratory settings. This platform utilizes mCodes™ technology, a unique protein barcoding system that enables the simultaneous study of multiple proteins in one experiment, making it particularly effective for complex biologics. Unlike other companies, Manifold Bio's approach to drug design is distinct because it integrates in vivo testing with advanced protein multiplexing capabilities. The company's goal is to expand their platform and collaborate with other pharmaceutical companies to develop new therapeutics.

Boston, MassachusettsHeadquarters
2020Year Founded
$58.8MTotal Funding
SERIES_ACompany Stage
Biotechnology, HealthcareIndustries
11-50Employees

Risks

Increased competition from companies like Insamo and Infinimmune.
Rapid AI and ML advancements may outpace Manifold Bio's current technology.
Regulatory challenges in in vivo testing could delay product development timelines.

Differentiation

Manifold Bio uses proprietary mCodes™ technology for protein multiplexing in drug design.
Their in vivo drug design platform is the first of its kind globally.
The company specializes in precision biologics, focusing on complex biologics development.

Upsides

Raised $40M in Series A funding, indicating strong market interest.
Their platform could revolutionize in vivo testing by testing multiple molecules simultaneously.
Strategic partnerships with multiple investors enhance growth and development opportunities.

Land your dream remote job 3x faster with AI